Lung cancer, Non small cell lung cancer (NSCLC)
Results
Phase 2
This trial looked at afatinib for non small lung cancer (NSCLC) for people who cannot have chemotherapy.
It was open to people with NSCLC that had, or was suspected to have, a change (mutation) in the EFGR gene.
The trial was open for people to join between 2013 and 2015. The team published the results in 2024.
Cancer Research UK supported this trial.
Recruitment start: 1 March 2013
Recruitment end: 13 August 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Sanjay Popat
Boehringer Ingelheim
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University College London (UCL)
This is Cancer Research UK trial number CRUKE/10/040.
Last reviewed: 06 Mar 2025
CRUK internal database number: 6974
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
